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Abstract 22 
Chronic viral infections represent a major challenge to host's immune response and 23 
a unique network of immunological elements, including cytokines, are required for 24 
their containment. By using a model persistent infection with the natural murine 25 
pathogen lymphocytic choriomeningitis virus clone 13 (LCMV Cl13) we investigated 26 
the role of one such cytokine, interleukin 27 (IL-27), in the control of chronic 27 
infection. We found that IL-27R signalling promoted control of LCMV Cl13 as early 28 
as day 1 and 5 after infection and that il27p28 transcripts were rapidly elevated in 29 
multiple subsets of dendritic cells (DCs) and myeloid cells. In particular, 30 
plasmacytoid DCs (pDCs), the most potent type-1-interferon (IFN-I) producing cells, 31 
significantly increased il27p28 in a TLR7 dependent fashion. Notably, mice deficient 32 
in IL-27 specific receptor (R), WSX-1, exhibited a pleiotropy of innate and adaptive 33 
immune alterations after chronic LCMV infection, including compromised NK cell 34 
cytotoxicity and antibody responses. While, the majority of these immune alterations 35 
appeared cell-extrinsic, cell-intrinsic IL-27R was necessary to maintain early pDC 36 
numbers, which, alongside lower IFN-I transcription in CD11b+ DCs and myeloid 37 
cells, may explain the compromised IFN-I elevation that we observed early after 38 
LCMV Cl13 infection in IL-27R-deficient mice. Together these data highlight the 39 
critical role of IL-27 in enabling optimal anti-viral immunity early and late after 40 
infection with a systemic persistent virus and suggest that a previously unrecognized 41 
positive feedback-loop mediated by IL-27 in pDCs might be involved in this process. 42 
 43 
Importance 44 
Persistently replicating pathogens such as Human Immunodeficiency virus, Hepatitis 45 
B virus and Hepatitis C virus represent a major health problem worldwide. These 46 
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infections impose a long-term challenge on the host immune system, which must be 47 
heavily and continuously regulated to keep the pathogen replication in check without 48 
causing fatal immunopathology. Using a persistently replicating rodent pathogen, 49 
lymphocytic choriomeningitis virus (LCMV), in its natural host we identified the 50 
cellular sources and effects of one important regulatory pathway, the interleukin-27 51 
receptor WSX-1 signalling, that is required for both very early and late restriction of 52 
chronic (but not acute) infection. We found that WSX-1 was necessary to promote 53 
innate immunity and the development of aberrant adaptive immune responses. This 54 
not only highlights the role of IL-27 receptor signalling in regulating distinct host 55 
responses that are known to be necessary to control chronic infections but also 56 
positions IL-27 as a potential therapeutic target for their modulation. 57 
58 
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Introduction 59 
Chronic infections with persistently replicating viruses, which includes the 60 
major human pathogens human immunodeficiency virus type 1 (HIV-1), hepatitis C 61 
virus (HCV) and hepatitis B virus (HBV), present the host with a life-long challenge. 62 
As a consequence infection by these pathogens often results in heavily regulated 63 
immune responses that aim to keep the persistent virus in check without causing 64 
fatal immunopathology. Such immune-regulation during chronic viral infections 65 
includes hypo-functionality of CD4+ and CD8+ T cells and delayed antibody 66 
production as well as rapidly attenuated, but sustained, type I IFN (IFN-I) responses 67 
(reviewed in (1)).  68 
Lymphocytic choriomeningitis virus (LCMV) is a small segmented RNA virus, 69 
of the Arenavidiae family, which cause natural vertically transmitted persistent 70 
infections in selective rodent hosts. LCMV has a strain dependent capacity to cause 71 
either acute e.g. LCMV Armstrong 53b (ARM) or chronic e.g. LCMV Clone 13 (Cl13) 72 
systemic infection in adult mice (2). Chronic infection of mice with LCMV Cl13 results 73 
in a systemic infection that is eventually cleared from the majority of tissues by 100 74 
days post infection (p.i.), sharing many common immunological features with 75 
persistent human infections (1). Clearance of LCMV Cl13 requires a combined effort 76 
of innate, B and T cell mediated immunity, as defects in any of these arms of the 77 
immune system results in lifelong viremia (3-5).   78 
Cytokine signalling can play pivotal roles in both promoting viral persistence 79 
and eventual control of LCMV. Increased signalling via IL-10 and TGF-β has been 80 
described during chronic LCMV infection and can dampen T cell responses (6-9). 81 
Exhausted virus specific T cells also become less responsive to the critical γc 82 
survival cytokines IL-2, IL-7 and IL-15 (10-12), although exogenous IL-2 and IL-7 can 83 
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be used therapeutically to promote viral control in an established LCMV Cl13 84 
infection (10, 13). IL-21, another γc cytokine, is crucial for maintenance of virus 85 
specific CD8+ T cell numbers during LCMV Cl13 infection (14-16). Meanwhile IL-6 is 86 
critical for maintaining virus specific CD4+ T responses by promoting TFH 87 
differentiation and virus specific antibody (17). The type I interferons (IFN-I), IFN-α 88 
and –β, are rapidly elevated and subsequently attenuated after chronic LCMV 89 
infection, playing an important, though complex, role in direct viral control and 90 
orchestration of immune responses (18-23).  91 
Interleukin 27 (IL-27) is a heterodimeric cytokine comprised of IL-27p28 and 92 
EBI3 subunits, making it structurally related to the IL-12 family of cytokines (reviewed 93 
in (24)). It signals through the common IL-6 cytokine family signal transduction 94 
molecule gp130 in conjunction with a cytokine specific receptor WSX-1 (encoded by 95 
Il27ra). Fitting with IL-27's use of gp130, downstream signalling primarily occurs 96 
through phosphorylation of STAT-1 and STAT-3, but IL-27 can also cause the 97 
phosphorylation of STAT-2, 4 and 5 (25, 26). WSX-1 is highly expressed on T cells 98 
and initial studies on the biological role of IL-27 focused on CD4+ and CD8+ T cells 99 
(27). In vitro IL-27 can upregulate CD8+ T cell expression of IFN-γ and granzyme B 100 
enhancing cytotoxic function (28), while on CD4+ T cells it promotes increased T-bet 101 
expression and T helper (Th) 1 differentiation (26). In regulatory T cells (Tregs) IL-27 102 
can regulate distinct functional characteristics (29, 30), while in helper T cells it is 103 
also associated with the production of IL-21 and suppression of Th17 responses (31-104 
34). During peptide vaccination IL-27 can be important in the generation of T 105 
follicular helper cells (TFH) (34). In contrast IL-27 signalling can also promote IL-10 106 
production by CD4 T cells in vivo (35, 36), in part via upregulation of Blimp-1, a 107 
transcriptional antagonist of TFH differentiation (37). IL-27 also influences other 108 
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immune cells, regulating natural killer (NK) cell cytotoxicity and cytokine secretion 109 
(38); upregulating CD39 on conventional DCs that results in enhanced suppression 110 
of T cell responses (39); and inhibiting viral replication in HIV and HCV infected cells 111 
in vitro (40-42).  112 
In contrast to their wild type (WT) counterparts, WSX-1 deficient mice develop 113 
life-long viremia after LCMV Cl13 infection (43). While intrinsic WSX-1 signalling is 114 
required for the optimal accumulation and maintenance of virus specific CD4+ T 115 
cells, CD4-T cell extrinsic mechanisms cause enhanced numbers of virus specific 116 
CD4+ T cells in WSX-1 deficient mice infected with LCMV Cl13, suggesting 117 
additional mechanisms underlying the lack of viral control in non-chimeric mice (43). 118 
In this study we found that IL-27 expression was rapidly increased after LCMV Cl13 119 
infection. Specifically, IL-27 was elevated in cDCs, plasmacytoid DCs (pDCs) and 120 
macrophages and this was fully dependent on TLR7 in pDCs but TLR-7-independent 121 
in cDCs and macrophages. Loss of IL-27 signalling resulted in reduced IFN-I and 122 
dysregulated DC and NK cell numbers and/or activation, which correlated with a 123 
diminished capacity to control LCMV Cl13 early after infection. Although, ubiquitous 124 
WSX-1 deficiency led to enhanced virus specific CD8+ T and plasmablasts cell 125 
numbers, virus specific antibody responses were diminished at later stages of 126 
infection, providing a possible explanation for the failure to control persistent 127 
replication late after infection. Importantly, mixed chimeras indicated that while most 128 
of the aforementioned immune-alterations were cell-extrinsic, IL-27 directly 129 
contributed to pDC accumulation early after chronic LCMV infection. These results 130 
reveal a previously unappreciated role for IL-27 in orchestrating early innate anti-viral 131 
responses and late humoral immunity, which associates with very early and late 132 
containment of a systemic persistent infection. In addition, our results suggest a 133 
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novel DC positive-feedback-loop, in which viral infection rapidly promotes production 134 
of DC and macrophage derived IL-27 directly promoting pDC accumulation and 135 
enhancing IFN-I transcription in cDCs early after infection. 136 
137 
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Materials and methods 138 
Mice and viral stocks. WT C57BL/6, WT CD45.1+ (B6.SJL-Ptprca Pepcb/BoyJ) and  139 
Il27ra-/- (WSX-1 deficient) mice were purchased from The Jackson Laboratory (Bar 140 
Harbor, Maine). Tlr7-/- mice were kindly provided by Professor Shizuo Akira (Osaka 141 
University, Japan).  For mixed bone marrow chimeras recipient mice received 1000 142 
Rads and were reconstituted with 5.0 x 106 (at a 50:50 ratio between the two donors) 143 
bone marrow cells i.v.. Chimeras were then allowed to reconstitute for 8 weeks prior 144 
to infection. Mice were bred and maintained in a closed breeding facility and mouse 145 
handling conformed to the requirements of the National Institutes of Health and the 146 
Institutional Animal Care and Use Guidelines of UCSD. Unless otherwise stated, 6-8 147 
week old mice were infected intravenously (i.v.) with 2 x 106 PFU of LCMV ARM or 148 
Cl 13. Viruses were grown, identified and quantified as described in (2, 44).  149 
Purification of DCs. Spleens were incubated with 1mg/mL collagenase D for 20 min 150 
at 37 ̊C and passed through a 100μm strainer to achieve a single cell suspension. 151 
Splenocytes were then incubated for 30 minutes with rat monoclonals (mAbs) 152 
specific for Thy1.2 and CD19 followed by magnetic cell sorting using anti-rat 153 
immunoglobulin-coated magnetic beads (Qiamag beads, Qiagen, Redwood City, 154 
CA) according to manufacturer’s instructions. The bead negative fraction of cells 155 
were then stained with a panel of fluorescently conjugated mAbs along with 156 
propidium iodide (PI) and FACS-purified using a BD ARIA II (BD) for pDCs (PI-157 
CD11cintermediate/dimCD11b-B220+PDCA+), CD11b+ cDCs (PI-CD11c+B220-158 
CD11b+CD8-), CD8+ DCs (PI-CD11c+B220-CD11b-CD8+) and other myeloid cells (PI-159 
CD11b+CD11c-) after B (CD19), T (Thy1.2) and NK (Nk1.1) cell exclusion. Purities 160 
were > 92 %.  161 
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Flow cytometry. Flow cytometry was carried out as described in (43). All antibodies 162 
and tetramers used for T cell identification and functional characterisation were also 163 
identical to those used in (43). Tetramers or monomers were kindly provided by NIH 164 
Tetramer Core Facility (Atlanta, GA). For DCs and macrophages the following anti-165 
mouse antibodies (from eBioscience unless otherwise stated) were used: anti-Thy 166 
1.2-PerCP-Cy5.5 (145-2C11), CD19-PerCP-Cy5.5 (eBio1D3), NK1.1-PerCP-Cy5.5 167 
(PK136), CD11b-PE-Cy7 (M1/70), B220-APC-eF780 (RA3-6B2), PDCA-1-FITC 168 
(eBio927), CD86-PE (IT2.2; Biolegend), CD8-eF450 (53-6.7). For NK cells 169 
identification freshly isolated splenocytes were surface stained with anti-NK1.1-170 
PerCP-Cy5.5 (PK136) and CD3e-eFlour450 (17A2). For Tbet analysis cells were 171 
then stained intranuclearly with anti-mouse/human-Tbet-FITC (4B10, Santa Cruz 172 
Biotech, Dallas, Tx) after fixation with the Foxp3 permeabilization and fixation kit 173 
(eBioscience). For granzyme B, Lamp-1 and IFN-γ staining splenocytes were 174 
incubated for 5 hours at 37oC in the presence of 1 ug/ml brefeldin A and anti-mouse 175 
CD107a/b-FITC (1D4B, Invitrogen). NK cells were stained for and cells fixed with 1% 176 
paraformaldehyde and permeabilized with saponin. Subsequently they were stained 177 
with IFN-γ-APC (XMG1.2) and anti-human Granzyme-B-PE (GB12, Invitrogen). Cells 178 
were acquired using the Digital LSR II flow cytometer (Becton Dickinson, San Jose, 179 
CA). Flow cytometric data were analyzed with FlowJo software (TreeStar, CA).  180 
Bone marrow derived DCs. Bone marrow (BM) cells were isolated from femurs and 181 
tibias and a single cell suspension was prepared and cultured 7-8 days in the 182 
presence of 100ng/ml Flt3L (Amgen, Thousand Oaks, CA & Cell Dex Therapeutics, 183 
Needham, MA) as previously described (45). Cells were stimulated with 0.1µM CpG 184 
B 1668 (Integrated DNA Technologies, San Diego, CA), 100 ng/ml LPS, 25 μg/ml 185 
PolyI:C and 100µM Loxoribine (Invivogen). 186 
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Real-time RT-PCR. Total RNA from sorted cells was extracted using RNeasy Micro 187 
kits (Qiagen) and reverse transcribed into cDNA using Superscript III RT (Invitrogen). 188 
Total RNA from spleen homogenates was extracted RNeasy mini kits (Qiagen) and 1 189 
μg of RNA was converted to cDNA using m-mLV reverse transcriptase kit (Promega, 190 
Madison, WI). cDNA quantification was performed using a Real-Time PCR Detection 191 
System (Applied Biosystems, Carlsbad, CA) by using SYBR green PCR kits. All 192 
genes were normalised to Gapdh as previously described (21). For SYBR green the 193 
following primers were used at 280 nM. Ifnα 4/6/7: F 5’-194 
TATGTCCTCACAGCCAGCAG-3’ R 5’-TTCTGCAATGACCTCCATCA-3’; Ifnβ1: F 5’-195 
CTGGCTTCCATCATGAACAA-3’ R 5’-GAGGGCTGTGGTGGAGAA-3; Tnfα F 5’-196 
CCCTCACACTCAGATCATCTTCT-3’ R 5’-GCTACGACGTGGGCTACAG-3’. 197 
Il27p28: F 5’-CTGTTGCTGCTACCCTTGCTT-3’ R 5’-198 
CACTCCTGGCAATCGAGATTC-3’. Ebi3: F 5’- ACAACTGAGCCACACTGGGCA-3’ 199 
R 5’- CCACACCGAGCCTGTAAGTGG-3’. LCMV GP: F 5’-200 
CATTCACCTGGACTTTGTCAGACTC-3’, R 5’-GCAACTGCTGTGTTCCCGAAA-3’. 201 
LCMV NP: F 5’-GCATTGTCTGGCTGTAGCTTA-3’, R 5’-202 
CAATGACGTTGTACAAGCGC-3’, Il18: F 5’-GCCTCAAACCTTCCAAATCA-3’, R 5’-203 
TGGATCCATTTCCTCAAAGG-3’. Il12p35: F 5’-AAATGAAGCTCTGCATCCTGC-3’, 204 
R 5’-TCACCCTGTTGATGGTCACG-3’ and Gapdh: F 5’- 205 
TCCCACTCTTCCACCTTCGA-3’, R 5’-AGTTGGGATAGGGCCTCTCTT-3. Human 206 
GAPDH: F 5’-TGATGACATCAAGAAGGTGGTGAAG-3’, R 5’-207 
TCCTTGGAGGCCATGTGGGCCAT-3’. For Il6 Taqman master mix (Applied Biosystems) 208 
was used in conjunction with the appropriate primers and probe from the Universal 209 
Probe Library (Roche).  210 
LCMV specific antibody ELISAs. LCMV specific ELISAs were done as we and 211 
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others have previously described using antigen prepared by purifying LCMV on a 212 
renograffin gradient (17).  Endpoint titers were calculated by determining the lowest 213 
dilution at which specific antibody was at least 2 x S.D. above background. For 214 
avidity assays, an LCMV specific Ig ELISA was performed. After incubation of serial 215 
dilutions serum on LCMV coated plates were washed 3 times with 8 M Urea or PBS 216 
prior to addition of an HRP conjugated anti-mouse Ig secondary (Southern Biotech, 217 
Birmingham, AL). The percentage binding was then determined as ODurea/ODPBS x 218 
100 at a 1/4000 serum dilution when both were in detectable above baseline.    219 
Cytokine detection. Total IFN-I bioactivity was measured by luciferase bioassay 220 
with reference to a recombinant mouse IFNβ standard (Research Diagnostics, 221 
Concord, MA) using a L-929 cell line transfected with an interferon-sensitive 222 
luciferase as previously described (46). IL-27, TNFα and IL-6 were measured by 223 
ELISA (eBioscience, La Jolla, CA). 224 
In vitro infection. A549 cells (ATCC) were cultured in DMEM (Lonza, Walkersville, 225 
MD, USA), supplemented with 2 mM L-glutamine, 50 U ml-1 penicillin and 50 mg ml-1 226 
streptomycin (Gibco, Grand Island, NY, USA), plus 10% heat-inactivated foetal 227 
bovine serum (Lonza). Cells were maintained in 175 cm2 flasks at a density of 0.5-228 
1x106 cells ml-1 in a total volume of 30 ml. 1 x 106 A549 cells were left untreated or 229 
pre-treated for 1 h with 20 or 100 ng ml-1 human recombinant IL-27 (Biolegend). 230 
Cells were subsequently infected with LCMV Cl13 at a multiplicity of infection (MOI) 231 
of 0.05 or 0.5. After 1 day, cells were washed with PBS and collected in lysis buffer 232 
(Qiagen) for RNA analysis. 233 
 234 
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Statistics. Statistical analysis was carried out using Graphpad Prism 5.0 (Graphpad, 235 
La Jolla, CA). For comparisons between 2 groups non parametric Mann-Whitney u 236 
test was performed. For comparison of multiple groups, Kruskal-Wallis test followed 237 
by a Dunn's comparison test. For pairwise analysis a Wilcoxon test was used. In all 238 
cases * P < 0.05, ** P < 0.01 and *** P < 0.005. 239 
240 
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 241 
Results 242 
IL-27 promoted early control of LCMV Clone 13 infection 243 
 We have previously reported that WSX-1 is not only required for long term 244 
viral control of LCMV Cl13, but also seems to regulate viral burden earlier in infection 245 
(43). Confirming this we found that Il27ra-/- mice had significantly increased viremia 246 
at days 5, 9 and 11 post infection (p.i.) with LCMV Cl13 infection compared to WT 247 
mice, with similar viral loads being seen at day 15 (Fig. 1A). Importantly in contrast 248 
there was no apparent defect in the ability of Il27ra-/- mice to control LCMV ARM, 249 
with viremia being undetectable by day 11 p.i.. Viral loads at timepoints earlier than 250 
day 5 p.i. are difficult to determine, especially within the first 24 hours post infection. 251 
The expression of lcmv gp and np in spleen homogenates were, however, both 252 
elevated in the absence of WSX-1 24 hours after LCMV Cl13 infection (Fig. 1B). 253 
 Taken together these data showed that IL-27 signalling was critical in 254 
promoting persistent viral control from a very early timepoint p.i. and appeared 255 
essential for long-term control of persistent (but not acute) LCMV infection (Fig. 1A 256 
and (43)).  257 
 258 
Systemic viral infection rapidly induced IL-27 up-regulation 259 
 Viral infection often results in the rapid production and release of many 260 
cytokines and chemokines, which prime and instruct the immune system. Many of 261 
these mediators are quickly dampened, while others are produced at heightened 262 
concentrations throughout infection or undergo several phases of production (17). 263 
Given that IL-27 signalling is crucial to contain the magnitude of early LCMV Cl13 264 
replication  (Fig 1A-B) we sought to determine the timing and cellular source of IL-27 265 
production early during LCMV Cl13 infection. 266 
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 IL-27 was undetectable in the serum at any time point analyzed (between day 267 
1 and day 30 post infection) after LCMV Cl13 infection (data not shown). WT C57B/6 268 
mice did however have constitutively detectable levels of IL-27 in whole spleen, 269 
which were increased at day 1 p.i. and return to basal naïve concentrations at days 8 270 
and 25 p.i. (Fig. 2A). Expression of Il27p28 transcript in whole spleen mirrored 271 
protein with detectable transcripts in naïve mice and significant increase at day 1, but 272 
not days 8 and 25, p.i. In contrast, splenic Ebi3 expression was unchanged 273 
throughout infection, or slightly reduced at day 25 p.i (Fig. 2B).  274 
 Having determined that IL-27 was elevated rapidly upon infection we next 275 
investigated which cells might be responsible for its production. CD8+ DCs and 276 
macrophages have previously been described to produce significant amounts of IL-277 
27 (47, 48). As DCs and macrophages are highly activated in response to LCMV 278 
(22) we analysed IL-27 production by these cells after LCMV infection, gating CD8+ 279 
DCs, CD11b+ DCs, pDCs and CD11c-CD11b+ (hereafter referred to as myeloid cells 280 
– all cell populations gated as shown in Fig 3E). There was detectable Il27p28 281 
expression in DC and myeloid subsets prior to infection that was highly up-regulated 282 
in the same cells 24 hours p.i. (Fig. 2C). Across the 4 independent experiments 283 
analysed it was however unclear if any single cell type up-regulated Il27p28 284 
significantly above that of the other cell types, suggesting up-regulation was similar 285 
between all cell types. In contrast Ebi3 expression was not dramatically up-regulated 286 
after infection. Similar patterns of Il27p28 elevation were seen in mice infected with 287 
the acute LCMV ARM at day 1 p.i.. Interestingly however by day 8 post infection 288 
Il27p28 expression was still increased, in pDCs isolated from Cl13, but not ARM, 289 
infected mice. None of the other cell types examined showed increased Il27p28 290 
expression at this later time point in either infection.  291 
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 Given that DCs rapidly produce IL-27 in response to LCMV infection in vivo 292 
we next evaluated whether this could be TLR mediated. Flt3L differentiated bone-293 
marrow DCs, a mixture of pDCs and CD11b+ DCs, showed rapid up-regulation of 294 
Il27p28 and Ebi3 in response to TLR7 (Loxoribine) or TLR9 (CpG) agonists and to a 295 
lesser extent or not at all upon TLR4 (LPS) stimulation (Fig. 2D). They did not 296 
respond to poly(I:C), a TLR3 agonist. Loxoribine, CpG and LPS, but not poly(I:C), 297 
stimulation also all led to detectable IL-27 protein in the culture supernatants (Fig. 298 
2D). As pDCs had not previously been described to produce IL-27, and had 299 
prolonged IL-27 expression after LCMV Cl13 infection, we lastly evaluated whether 300 
TLR7 signalling, known to be essential for pDC IFN-I production during LCMV 301 
infection (22), played a role in the in vivo production of IL-27. Indeed Il27p28 and 302 
Ebi3 upregulation was completely ablated in pDCs, taken from Tlr7-/-  LCMV infected 303 
animals (Fig. 2E). TLR7 deficiency did not, however, affect IL-27 expression by the 304 
other DC or myeloid cell types analyzed.  305 
 Taken together these data indicated that IL-27 was produced by various 306 
innate cellular sources early after LCMV infection and this elevation was mostly 307 
transient in DCs and macrophages, but more sustained in pDCs after persistent 308 
LCMV infection. In particular pDC (but not cDC) production of IL-27 was fully 309 
dependent on TLR7.   310 
 311 
IL-27 regulated early innate immune responses after LCMV infection 312 
 LCMV infection results in rapid activation of the host's immune response, 313 
including production of high levels of IFN-I (22). Early IFN-I signalling can be vital in 314 
establishing an anti-viral environment early during infection by the induction of gene 315 
networks known to perturb viral replication and activate a range of immune cells (49). 316 
 o
n
 April 16, 2018 by Im
perial College London
http://jvi.asm.org/
D
ow
nloaded from
 
IL-27 signalling in systemic viral infection  J Virol 
 
16 
 
Compared to WT mice, Il27ra-/- mice had significantly lower circulating bioactive IFN-317 
I 24 hours after infection with LCMV ARM or Cl13 (Fig. 3A). Absence of WSX-1 also 318 
resulted in failure to upregulate both Ifna and Ifnb in the spleen after LCMV Cl13 319 
infection (Fig. 3B). Contrastingly the pro-inflammatory mediators IL-6 and TNF were 320 
both significantly increased in the serum from Il27ra-/- versus wild type mice 24 hours 321 
post Cl13 infection (Fig. 3C). Il6, Tnf and Il18 expression were also significantly 322 
higher in the spleens of Il27ra-/- mice compared to WT controls, but expression of 323 
Il12p35 was similar in WT and WSX-1 deficient mice (Fig. 3D). 324 
 In LCMV infection IFN-I is produced by both pDCs, via a TLR7 dependent 325 
pathway, and cDCs and macrophages, where production is dependent on MAVS 326 
and MDA5 (22, 50, 51). Uninfected Il27ra-/- mice had similar numbers of pDCs, cDCs 327 
and other myeloid cells to WT mice in their spleen (Fig 3E). The number of CD8+ 328 
DCs, CD11b+ DCs and CD11c-CD11b+ myeloid cells in the spleen 24 hours after 329 
infection was unaffected by Il27ra deletion however the number of pDCs at this time 330 
point was significantly reduced, by approximately 2-fold, in Il27ra-/- mice compared to 331 
WT mice (Fig. 3E). Expression of IFN-I genes by the different cell populations was 332 
variably affected by the absence of WSX-1. Other myeloid cells had significantly 333 
reduced Ifna and CD11b+ DCs had significantly reduced Ifna and Ifnb but CD8+ DCs 334 
had increased Ifnb expression (Fig 3F). Meanwhile Ifna and Ifnb expression by 335 
pDCs, which had the highest expression of both IFN-Is in a per cell basis (22), were 336 
unaffected by WSX-1 deletion (Fig 3F). In addition up-regulation of the co-stimulatory 337 
molecule CD86 was adversely affected on all four innate cell populations (Fig. 3G). 338 
 Natural Killer (NK) cells, responding to changes in the cytokine milieu, also 339 
promptly respond to LCMV infection. The number of NK cells in the spleen both prior 340 
to, and 24 hours after, infection was unaffected by the deletion of Il27ra (Fig. 4A). 341 
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Interestingly however the functionality of NK cells 24 hours post LCMV Cl13 infection 342 
was altered, with Il27ra-/- NK cells showing reduced granzyme B and increased IFN-γ 343 
production compared to WT NK cells (Fig. 4B). Specifically it appeared from the 344 
gating that the proportion of Granzyme B positive Il27ra-/- NK cells was similiar to that 345 
seen in WT NK cells (data not shown), but the per cell expression of granzyme B in 346 
Granzyme B positive NK cells was significantly lower (Fig 4B). Likewise, while there 347 
was a small increase in the proportion of IFN-γ+ NK cells in Il27ra-/- mice compared 348 
to WT mice, the biggest change was the overall amount of IFN-γ per NK cell (Fig 349 
4B). Surprisingly, given the increased IFN-γ production, NK cells from Il27ra-/- mice 350 
had decreased T-bet, a known positive regulator of IFN-γ production, compared to 351 
WT mice (Fig. 4C). This was accompanied by reduced degranulation, as measured 352 
by LAMP-1 (Fig. 4D). 353 
 These data showed that signalling through IL-27 regulated a number of critical 354 
innate immune parameters very early after systemic LCMV infection. These changes 355 
should, however, be considered in the light of the increased viral RNA (Fig. 1B), 356 
suggesting more viral replication, which could impact the degree of stimulation or 357 
inhibition of a particular pathway in cells from Il27ra-/- versus WT infected mice  358 
 359 
Direct IL-27 signalling favours pDC accumulation early after LCMV Cl13 infection  360 
To dissect between IL-27 mediated restriction of viral replication that 361 
subsequently impacts innate cell numbers and function versus direct regulation of 362 
innate cells by IL-27, we first investigated a putative role of IL-27 in directly 363 
controlling LCMV growth, independently of innate immune cells. Pre-treatment of 364 
LCMV susceptible cells (i.e. A549 cells) with increasing doses of rIL-27 before LCMV 365 
Cl13 infection had no effect on viral replication (Fig. 5A). This suggested that IL-27 366 
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could not increase an antiviral state in LCMV susceptible cells and that the enhanced 367 
viral growth early after chronic LCMV infection was unlikely a consequence of cell-368 
intrinsic defective viral control in infected cells and may instead result from the 369 
aforementioned altered innate cell responses. 370 
To further discern between cell-intrinsic versus cell-extrinsic innate cell 371 
defects in the absence of il27ra signalling we generated CD45.1:Il27ra-/- and 372 
CD45.1:C57BL/6 WT mixed bone marrow chimeras and analysed DCs and NK cells 373 
24 hours post LCMV Cl13 infection. Il27ra-/- cDCs were slightly reduced in frequency 374 
when compared to both cDCs from the CD45.1+ compartment, and CD45.2+ DCs 375 
from control chimeras (Fig. 5B), but this was not observed in non-chimeric Il27ra-/- 376 
mice (Fig. 3E). In contrast, the more pronounced intrinsic defect in the numbers of 377 
Il27ra-/- pDCs 24 hours after LCMV Cl13 infection when compared to WT pDCs (Fig. 378 
5C) was in agreement with the reduced pDC accumulation observed in the Il27ra-/- 379 
mice 1 day p.i. (Fig. 3E). CD86 expression by both pDCs and cDCs, which we had 380 
seen decreased in non-chimeric WSX-1-deficient mice (Fig. 3G), was actually 381 
significantly increased in Il27ra-/- compared to their CD45.1+ WT counterparts in bone 382 
marrow chimeras, but this effect was also observed in the CD45.1:WT control 383 
chimeras (Fig. 5D). Intrinsic IL-27R signalling appeared to have no role in controlling 384 
NK cell frequency or function, as measured by expression of T-bet, IFN-γ and 385 
granzyme B, at day 1 after LCMV Cl13 infection (Fig. 5E). None of the 386 
aforementioned DC or NK phenotypes appeared affected in Il27ra-/- versus WT cells 387 
before infection (Fig. 5B-E). 388 
Given the aforementioned cell-intrinsic effect of IL-27 in pDCs, we next 389 
investigated the direct effect of recombinant IL-27 on uninfected BM-Flt3L derived 390 
DCs (which contain pDCs), in the absence or in the presence of TLR7 ligand 391 
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loxoribine, independently of the infectious environment. Under these conditions, we 392 
could not detect any effect of recombinant IL-27 on either unstimulated or TLR-7-393 
stimulated pDC viability or numbers (Fig. 5F and not shown), suggesting that the 394 
cell-intrinsic IL-27 induction of pDC maintenance observed in vivo may result from 395 
modulation of regulatory mechanisms that are not recapitulated in BM-derived pDCs. 396 
Furthermore, addition of rIL-27 to BM-derived DCs stimulated with Loxoribine did not 397 
significantly affect IFN-I production with only a slight increase reaching statistical 398 
significance compared to controls in 1 out of 3 independent experiments (Fig. 5G). 399 
Note that upon loxoribine stimulation only BM-derived pDCs but not BM-derived cDC 400 
produce IFN-I (data not shown).  401 
Overall, these data showed that the majority of early defects seen in the 402 
innate immune responses in the global absence of WSX-1 after LCMV Cl13 were 403 
cell extrinsic. The exception was the effect on pDCs, which required IL-27 signalling 404 
to optimally maintain their numbers early after infection.  405 
 406 
Il27ra shapes the adaptive immune response to chronic LCMV  407 
 Viral containment of persistent LCMV variants requires a combination of 408 
innate, CD8+ and CD4+ T cells and antibody mediated immunity as impairment of any 409 
one of these compartments can allow virus to persist indefinitely (3-5, 52). Given that 410 
early innate immune responses are crucial to prime and sustain the adaptive 411 
response to infection, and the prior observation that late control of LCMV Cl13 412 
persistence is WSX-1 dependent (43) we next sought to determine the effect of 413 
Il27ra deletion on the generation of LCMV specific T cell and B cell responses. 414 
 IL-27 has been implicated in the proliferation and differentiation of antigen 415 
specific CD8+ T cell responses (28, 53, 54). Il27ra-/- mice had significantly fewer 416 
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DbGP276-284
+
 CD8
+ T cells than WT mice. In the spleen there were significantly 417 
increased numbers of DbNP396-404
+ and DbGP33-41
+ CD8+ T cells at day 9 p.i, in the 418 
absence of WSX-1 (Fig. 6A). By day 30 p.i., however, the numbers of LCMV-specific 419 
CD8 T cells were similar between WT and KO mice. Il27ra-/- mice also had slightly 420 
increased numbers of blood LCMV specific DbNP396-404
+ and DbGP276-284
+ CD8+ T 421 
cells at days 9 and 15 p.i., but these differences did not reach statistical significance 422 
(Fig 6B). These differences declined as the infection progressed and by day 45 p.i. 423 
Il27ra-/- mice had fewer circulating GP276-284-specific CD8 T cells than WT mice. The 424 
functional capacity of GP33-41 stimulated CD8
+ T cells to hierarchically produce IFN-γ, 425 
TNF and IL-2 was similar between WT and Il27ra-/- mice at both day 9 and 30 p.i. 426 
(Fig. 6C). Despite this PD-1 expression, a key marker of T cell exhaustion during 427 
chronic infection, by virus specific CD8+ T cells was significantly lower in the 428 
absence of WSX-1 at day 9 p.i. and trended the same way at day 30 p.i. (Fig. 6D). In 429 
comparison to chronic LCMV during acute LCMV infection circulating Db NP396-404
+ 430 
CD8+ T cell numbers were similar in WT and Il27ra-/- mice throughout infection, 431 
however Db GP33-41
+ numbers were elevated in the absence of WSX-1 (Fig. 6E).  432 
 Gp130 on virus specific CD4+ T cells is required for their survival, and 433 
differentiation into Tfh, during LCMV ARM or Cl13 infection under competitive 434 
conditions (43, 55). In Il27ra-/- mice however the number of virus specific CD4+ T 435 
cells was actually heightened at day 9 after LCMV Cl13 infection, though it returned 436 
to numbers similar to WT mice at day 30 p.i. (43). One remaining question from 437 
these studies was whether IL-27, given its importance in determining CD4+ T cell 438 
differentiation in other inflammatory and infectious environments (32, 34), regulated 439 
CD4+ T cell fate during LCMV infection. Neither TFH nor Treg frequencies were 440 
affected by WSX-1 deletion at days 9 and 30 after LCMV Cl13 infection (Fig 6F & G).  441 
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At the same time points secretion of IFN-γ, TNF and IL-21, a key anti-viral cytokine 442 
and potential downstream target of IL-27, by virus specific CD4+ T cells were all 443 
similar (Fig 6H). 444 
Virus specific antibody responses are also vital for containment of chronic 445 
LCMV infection (5). Germinal centre B cell numbers were similar in WT and WSX-1 446 
deficient mice at days 9 and 30 post LCMV Cl13 infection (Fig. 7A). Il27ra-/- mice did 447 
however have a population of B cells that were CD38-GL7- in their spleens at day 9 448 
p.i. that was not observed in WT mice. Further evaluation of B cell subsets revealed 449 
that these cells represented a subset of CD138+ B cells and Il27ra-/- mice had 450 
significantly more of these IgD- plasmablasts than WT mice at day 9 post infection 451 
(Fig. 7B). Perhaps counter intuitively, given the larger number of plasmablasts, 452 
Il27ra-/- mice had slightly reduced LCMV specific IgG by day 30 p.i. and absence of 453 
IL-27R led to deficiency in both LCMV specific IgG2a and IgG1 (Fig. 7C) and slightly 454 
affected IgG avidity at day 30 p.i., although this was similar to that seen in WT mice 455 
by day 60 (Fig. 7D). Loss of IL-27R signalling did not affect the amount, type or 456 
quality of antibodies produced in response to acute LCMV ARM infection, nor was 457 
antibody induction on re-challenge with LCMV Cl13 affected (Fig. 7E and F).  458 
To determine if the changes in the adaptive immune response in the absence 459 
of Il27ra were a result of the altered viral and inflammatory environment, or direct 460 
signalling on B and T cells, we next analyzed responses in mixed bone marrow 461 
chimeras. In contrast to the cell-intrinsic IL-27R regulation of LCMV-specific CD4 T 462 
cell numbers late after LCMV Cl13 infection (43), we observed that there were 463 
similar frequencies of both virus specific CD8+ T cells, and their PD-1 expression, in 464 
the WT and Il27ra-/- compartments of CD45.1:Il27ra-/- mixed bone marrow (BM) 465 
chimeras at both days 9 and 30 after LCMV Cl13 infection (Fig. 8A). We also saw no 466 
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significant difference in GC B cell or plasmablast frequencies at either timepoint p.i. 467 
(Fig. 8B and C).  468 
Together these data showed that IL-27 signalling affected adaptive responses 469 
by decreasing virus-specific antibody responses despite increasing the number of 470 
virus specific CD8 T cells and plasmablasts. Notably, only from day 30 p.i. onward, 471 
when viral loads were once again significantly different in WT and Il27ra-/- mice (43), 472 
did virus specific antibodies begin to become adversely affected. Importantly similar 473 
defects were not seen in the generation of immunity against LCMV ARM, and when 474 
wild type and Il27ra-/- deficient GC B and plasmablasts were in the same 475 
environment their frequencies were comparable. Although there may be some IL-27 476 
intrinsic effects on parameters not studied here, our data suggested that the 477 
environment induced by IL-27R signalling is likely a key driver of the antibody 478 
induction during chronic LCMV infection. Even if B cell-extrinsic, however, the 479 
aforementioned defective antibody responses could contribute to the inability of 480 
Il27ra-/- mice to clear LCMV Cl13 infection.  481 
482 
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Discussion 483 
 Containment of continuously replicating chronic viral infections requires a 484 
combined effort from innate cells, T cells and antibodies (1). Here we found that 485 
during chronic LCMV infection IL-27 deficiency was associated with dysregulation of 486 
the innate immune response and failure to contain early viral replication. IL-27 was 487 
enhanced rapidly by DCs and other myeloid cells upon infection, with pDCs in 488 
particular up-regulating IL-27 transcripts in a TLR7 dependent fashion. Early IL-27 489 
signalling aided in promoting peak IFN-I elevation, NK cell cytotoxic program and DC 490 
activation. This aberrant inflammatory response was associated with disrupted 491 
adaptive immune responses at later stages of infection and life-long viremia (43).   492 
 IL-27 signalling has a well-described role in T cell responses, where it 493 
regulates both the differentiation and function of both CD4+ and CD8+ T cells, in 494 
particular promoting Tbet and IFN-γ production (25, 26, 28). IL-27 can also play a 495 
critical immunoregulatory role, suppressing IL-2 production by CD4 T cells (56), and 496 
promoting their IL-10 production (35-37). Fitting with this IL-27R signalling has a 497 
negative impact on immune protection after chronic infections such as Mycobaterium 498 
tuberculosis or murine cytomegalovirus (57, 58). In contrast, we have previously 499 
shown that IL-27R signalling is critical for promoting immune protection during 500 
chronic LCMV infection, where cell-intrinsic IL-27R signalling promotes survival of 501 
virus specific CD4+ T cells when IL-27R deficient and sufficient CD4+ T cells are 502 
placed in competition during chronic LCMV infection (43). Notably, ubiquitous IL-27R 503 
signalling deficiency resulted in increased numbers of virus specific CD4+ T cells at 504 
day 9 p.i. (43), but here we show that it does not affect their cytokine secretion, TFH 505 
differentiation or the frequency of Foxp3+ regulatory T cells; both of which IL-27 can 506 
modulate under different conditions (34, 43). Global loss of IL-27R signalling also 507 
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increases the number of LCMV specific CD8+ T cells after both chronic and acute 508 
infection, but as with the increase in CD4 T cell numbers, this is not a cell intrinsic 509 
effect and loss of IL-27R does not adversely affect the functional capacity of the CD8 510 
T cell response. Although further studies may bring about additional IL-27 effects on 511 
T cells, our work highlights selected cell-intrinsic versus extrinsic as well as the 512 
context specific roles of IL-27R signalling on T cell responses against a systemic 513 
persistent pathogen. 514 
 While we could not observed major alterations in T cell responses from WSX1 515 
deficient mice by day 30 p.i., prior to the establishment of life-long viral infection, 516 
there were more notable reductions in the quantity and quality of LCMV specific 517 
antibodies. We and others have previously reported that antibody responses are 518 
critical for the control of chronic LCMV infection (5, 17, 59). IL-27 has been shown to 519 
influence TFH formation and function in certain circumstances (34, 43) and it can also 520 
directly act on B cells. In human B cell cultures IL-27 signalling has the capacity to 521 
regulate the proliferation of naive B cells, their differentiation into plasma cells and 522 
isotype switch (60, 61), while in similar cultures using murine B cells it was found to 523 
up-regulate T-bet and promote IgG2a switch (62). In chronic LCMV infection, IL-27 524 
signalling does not appear to diminish GC B cell differentiation, although it does limit 525 
the emergence of plasmablasts. Importantly, however, during LCMV Cl13 infection 526 
IL-27 limited the production of LCMV specific IgG2a and IgG1 along with overall IgG 527 
avidity. IL-27 signalling did not affect either the production or type of antibody after 528 
acute LCMV infection, where viral clearance is maintained in the absence of IL-27, 529 
nor does cell-intrinsic IL-27 signalling appeared important for GC B cell or 530 
plasmablast numbers. Taken together, our data show that intrinsic IL-27R signalling 531 
has modest effects on the outcome of multiple aspects of adaptive immune 532 
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responses studied here. It is therefore likely that the reduced levels of LCMV-specific 533 
IgGs seen in chronically infected Il27ra-/- mice resulted, at least in part, from their 534 
increased viral loads and inflammatory state.  535 
Crucially there were significant effects on the innate inflammatory response in 536 
the absence of IL-27 signalling. Notably IFN-I production, which peaks 24 hours after 537 
LCMV infection (21), was significantly reduced in the absence of IL-27 signalling. 538 
IFN-I promotes an anti-viral state in cells through the induction of hundreds of 539 
interferon stimulated genes (ISGs) via phosphorylation of STAT-1 and STAT-2 (49). 540 
A reduction in this process would explain the reduced viral control seen at early time 541 
points post LCMV Cl13 infection and it is possible that high viral loads at early time 542 
points contribute to the viral persistence at later stages. Signalling through IFNαβR is 543 
critical for control of LCMV Cl13 persistence, and its absence results in enhanced 544 
depletion and exhaustion of virus specific T cells (52), though sustained IFN-I 545 
signalling also has a deleterious effect on T cell responses (18, 19). Thus, it is 546 
conceivable that reduced IFN-I levels in Il27ra-/- mice early after LCMV Cl13 infection 547 
could contribute to failure of viral control at later points post infection. In this study we 548 
have not evaluated whether IL-27R signalling influences chronic IFN-I signalling as 549 
well. An alternative option is that IL-27 itself may drive a cell-intrinsic anti-viral state 550 
that protects the mice from LCMV infection. IL-27 can phosphorylate STAT-1 (25, 551 
42) and has been shown to have anti-viral activity against other persistent viral 552 
infections including both HIV and Hepatitis C virus (41, 42). During HIV infection this 553 
process is related to IL-27’s ability to upregulate a subset of ISGs independently of 554 
IFN-I (41) and promote a number of anti-HIV molecules (63, 64), however we show 555 
here that, at least when used in vitro, IL-27 appears to have no restrictive effect in 556 
LCMV growth, making this hypothesis less likely. Interestingly however IFN-I itself is 557 
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also capable of driving IL-27 induced anti-viral activity (65). During LCMV infection 558 
IL-27 is produced by pDCs, cDCs and other myeloid cells, the same cells reported to 559 
produce the majority of IFN-I (50, 51), and indeed pDCs require TLR7 to produce 560 
both IFN-I (22) and IL-27. Further CD11b+ DCs and other CD11b+ myeloid cells from 561 
Il27ra-/- mice had reduced Ifna and Ifnb transcription, while intrinsic WSX-1 signalling 562 
after LCMV Cl13 infection was also critical for maintenance of pDCs, which are 563 
major sources of IFN-I in vivo (22).  Taken together these findings suggest that an 564 
IL-27 positive feedback loop may contribute to maintenance of pDC numbers very 565 
early after infection and to IFN-I production from myeloid cells, and that disabling 566 
such a loop could compromise peak IFN-I responses and viral control.  567 
IL-27 deficiency also affected NK cell and DCs activities. The consequence of 568 
compromised DC maturation in the absence of IL27R signalling early after chronic 569 
LCMV infection, are difficult to dissect given IL-27R deficient mice also had 570 
heightened antigen burden at these early time points. On the other hand, IL-27 can 571 
enhance NK cell anti-tumour activity including up-regulation of Tbet and granzyme B 572 
in vivo (38), both of which we found to require IL-27 for optimal up-regulation after 573 
LCMV Cl13 infection. One surprising observation was that in the absence of global 574 
IL-27R signalling IFN-γ production by NK cells increased, but Tbet expression 575 
decreased. IFN-γ is a target gene of Tbet in NK cells, and IFN-γ and Tbet are 576 
commonly induced by the same stimuli, although Tbet is not an absolute requirement 577 
for IFN-γ production by NK cells (66).  In human NK cells IL-27 can directly up-578 
regulate Tbet in NK cells as it does in T cells (67), however in vivo there is a 579 
suggestion that IL-27 acts indirectly to promote NK cell activity (68). One hypothesis 580 
is that Eomes, another key regulator of NK cell function (69), compensates for the 581 
slightly lower expression of Tbet in the absence of IL-27R. Critically, however, Il27ra-582 
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/- NK cells display none of the defects found in IL-27R deficient animals when they 583 
were placed in the same environment as WT NK cells showing that none of the 584 
defects observed in NK cells are the result of direct IL-27 signalling.  One 585 
mechanism by which NK cells activity could be modulated is through promotion of IL-586 
12 production by DCs however we found no difference in the levels of Il12p35 in the 587 
spleen. We did however find higher expression of Il18 in Il27ra-/- mice, and IFN-γ 588 
production by NK cells is known to be heavily induced by IL-18, synergistically with 589 
IL-12 (70, 71), which may explain the heightened IFN-γ production by NK cells from 590 
IL-27R deficient infected mice. NK cell activity is traditionally considered to be anti-591 
viral (reviewed in (72)). During chronic infection with LCMV, however, the dominant 592 
role of NK cells appears to be in curbing virus specific T cell responses and 593 
preventing the development of immunopathology, rather than reducing viral load (73, 594 
74). Thus, the reduced NK cell cytotoxic program may also help explain the 595 
increased numbers of virus specific CD8+ and CD4+ T cells that we observed in IL-596 
27R deficient mice.  597 
In conclusion, our study demonstrated that ubiquitous IL-27R deficiency 598 
affected anti-viral immunity at multiple junctures during a systemic chronic viral 599 
infection in vivo. In contrast to previous studies that focus on IL-27's ability to 600 
regulate T cells, we report here that IL-27R signalling largely influenced innate 601 
immunity and altered the inflammatory environment after infection, likely influencing 602 
long-term immunity. This was associated with IL-27's ability to promote very early as 603 
well as late pathogen containment during chronic viral infection.  604 
 605 
Acknowledgements 606 
 o
n
 April 16, 2018 by Im
perial College London
http://jvi.asm.org/
D
ow
nloaded from
 
IL-27 signalling in systemic viral infection  J Virol 
 
28 
 
This work was supported by National Institutes of Health Grants AI081923 and 607 
AI0113923 (to E.I.Z.). J.A.H. was supported by an Irvington Institute postdoctoral 608 
fellowship from the Cancer Research Institute and by a Wellcome Trust/Royal 609 
Society Sir Henry Dale fellowship (Grant 101372/Z/13/Z). E.I.Z. supervised the 610 
design, analysis and interpretation of all experiments described. J.A.H. and E.I.Z. 611 
initiated the study and designed the experiments. J.A.H., K.A.W., S.D., Y.J. P.B., 612 
A.D. E.J.W. and M.M. carried out experiments, analyzed the data and interpreted the 613 
results. J.A.H. and E.I.Z. wrote the manuscript with input from K.A.W., M.M., E.J.W. 614 
and S.D. We would also like to thank Justine Swann for technical assistance. 615 
616 
 o
n
 April 16, 2018 by Im
perial College London
http://jvi.asm.org/
D
ow
nloaded from
 
IL-27 signalling in systemic viral infection  J Virol 
 
29 
 
Figure Legends 617 
 618 
Fig. 1. Il27ra-/- mice had increased viral load early after chronic, but not acute, 619 
LCMV infection. WT and Il27ra-/- mice were infected with 2 x 106 pfu of LCMV Cl13 620 
i.v.. (A) Serum viral loads were determined at multiple time points post infection and 621 
compared with WT and Il27ra-/- mice infected with 2 x 106 LCMV Arm i.v.. (B) lcmv gp 622 
and np expression were determined in the spleen homogenates of LCMV Cl13 623 
infected WT and Il27ra-/- mice 24 hours post infection. A represents n = 10 mice per 624 
time point per group from 2 independent experiments. B and C are representative of 625 
2 independent experiments and n = 5 mice per group. 626 
  627 
Fig. 2. Dendritic cells and other myeloid cells were major producers of IL-27 628 
within 24 hours post LCMV infection in vivo.  629 
Wild type C57B/6 mice were infected with 2 x 106 pfu of LCMV Cl13 i.v. and (A) the 630 
concentration of IL-27p28 and (B) expression of Il27p28 and Ebi3 were determined 631 
in spleen homogenates at days 1, 8 and 25 p.i. and compared to uninfected (unif) 632 
levels. (C) WT mice were infected with LCMV Cl13 or Arm 53b and expression of 633 
Il27p28 and Ebi3 relative to Gapdh determined in FACS purified splenic pDCs 634 
(CD19- Thy1.2- NK1.1- CD11c+ CD11b- B220+ PDCA1+), CD8+ DCs (CD19- Thy1.2- 635 
NK1.1- CD11b- B220- CD8+ CD11c+), CD11b+ DCs (CD19- Thy1.2- NK1.1- CD8- 636 
CD11b+ CD11c+)  and myeloid cells (CD19- Thy1.2- NK1.1- CD11c- CD11b+). (D) 637 
Il27p28 and Ebi3 expression by qPCR, and IL27p28 protein by ELISA were 638 
determined in TLR agonist stimulated DCs from BM-Flt3L cultures. (E) Expression of 639 
Il27p28 and Ebi3 determined as in (C) with WT or Tlr7-/- mice at day 1 post LCMV 640 
Cl13 infection. A & B are representative of 3 independent experiments with n ≥ 3 641 
mice per group. C is cumulative of 4 independent repeats of n n ≥ 5 mice. D & E are 642 
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representative of n = 2 independent experiments with n ≥ 3 mice per group. *** p < 643 
0.001, ** p < 0.01 and * p < 0.05.  644 
 645 
Fig. 3 IL-27 regulated IFN-I and DC responses after LCMV infection.  646 
WT or Il27ra-/- mice were infected with 2 x 106 pfu of LCMV ARM (A), Cl13 or left 647 
uninfected (A-G) and analysed 24 hrss p.i. (A) Serum IFN-I was measured by 648 
bioassay. (B) Ifna4/6/7 and Ifnb expression was measured in spleen homogenates. 649 
(C) Serum IL-6 and TNF by ELISA. (D) Il6, Tnf, Il18 and Il12p35 expression in spleen 650 
homogenate. (E) The number of splenic DCs was determined by FACS. (F) Ifna and 651 
Ifnb expression was determined in FACS isolated DCs. (G) CD86 expression in DC 652 
subsets was determined by flow cytometry. Data represents n = 3 experiments of n ≥ 653 
4 mice per group.  654 
 655 
Fig. 4.  IL-27R signaling regulated NK cell function after LCMV infection.  656 
WT and Il27ra-/- mice were infected with 2 x 106 pfu of LCMV Cl13 i.v. and analyzed 657 
at 24 hs p.i. (D1) and compared to uninfected mice (U). (A) Spleen NK cell numbers 658 
(NK1.1+ CD3- CD19-) were enumerated by flow cytometry along with their expression 659 
of (B) granzyme B and IFN-γ, (C) T-bet and (D) LAMP-1. Granzyme B, IFN-γ and 660 
LAMP-1 were measured after incubation of splenocytes in the presence of brefeldin-661 
A for 5 hours. Data representative of n = 3 experiments of n ≥ 4 mice per group. 662 
 663 
Fig. 5. IL-27 has no direct anti-viral effect and extrinsic Il27ra signalling 664 
promotes optimal NK and DC activation after LCMV Cl13 infection 665 
(A) A549 cells were infected with 0.05 or 0.5 MOI of LCMV Cl13 with or without 666 
treatment with increasing doses rIL-27 from 1 hour prior to infection. Lcmv gp 667 
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expression was determined by RT-qPCR. (B-E) WT:C57BL/6 or WT:Il27ra-/- mixed 668 
bone marrow chimeras were infected with 2 x 106 pfu LCMV Cl13 i.v. or left 669 
uninfected and 24 hours p.i. the spleen was analyzed for (B) The frequency of cDCs 670 
(CD11b+ DCs),  (C) the frequency of pDCs and (D) CD86 expression by cDCs and 671 
pDCs. (E) The frequency and IFN-γ, T-bet and Granzyme B expression of NK cells. 672 
(F & G) Flt3L derived BMDCs (F & G) were stimulated with loxoribine in the 673 
presence or absence of 50 ng/ml rIL-27. (A) represent n = 4 per condition from 2 674 
independent experiments. (B-E) represent n = 6 uninfected controls, 5 uninfected 675 
Il27ra-/- chimeras, 4 infected controls and 8 infected Il27ra-/- chimeras from 2 676 
independent experiments. (F & G) n = 3 cultures per condition and representative of 677 
3 independent experiments.  678 
 679 
Fig. 6. IL-27 signalling has limited effects on T cell responses during LCMV 680 
infection 681 
WT and Il27ra-/- mice were used throughout. (A-D) The number of splenic Db NP396-682 
404
+ and Db  GP33-41
+ CD8+ T cells (A), the number of circulating Db NP396-404
+ and Db  683 
GP276-284
+ CD8+ T cells (B), the cytokine secretion by splenic CD8+ T cells after ex 684 
vivo GP33-41 peptide stimulation (C), and PD-1 expression by splenic D
b  GP33-41
+ 685 
CD8+ T cells after LCMV Cl13 infection was determined by flow cytometry. (E) The 686 
frequency of Db NP396-404
+ and Db  GP33-41
+ CD8+ T cells in the blood was determined 687 
after infection with 2 x 106 pfu of LCMV ARM i.v. (F-H) The frequency of Tfh, gated 688 
as CXCR5+ ICOS+ SLAM- CD4+ (E), Foxp3+ CD4 T cells (F) and cytokine secreting 689 
CD4 T cells in response to GP67-77 peptide stimulation (H) were determine in the 690 
spleens of LCMV Cl13 infected mice. Data is represent n ≥ 4 mice per group and is 691 
representative of at least 2 independent repeats. 692 
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 693 
Fig. 7. IL-27 deficiency results in reduced antibody responses in chronic, but 694 
not acute, infection 695 
WT and Il27ra-/- mice were infected with 2 x 106 pfu of LCMV Cl13 i.v. and (A) the 696 
number of germinal centre B cells and (B) at day 9 p.i. the number of CD138+ 697 
plasmablasts. (C) LCMV specific IgG, IgG2a/c and IgG1 and (D) IgG avidity were 698 
measured in the serum. (E-F) WT and Il27ra-/- mice were infected with 2 x 106 pfu of 699 
LCMV ARM i.v. and (E) serum LCMV-specific IgG2a and IgG1 determined before 700 
and after a re-challenge with LCMV Cl13. (F) Avidity of LCMV specific IgG in the 701 
serum. Data are representative of 2 independent experiments on n ≥ 4 mice per time 702 
point per group 703 
 704 
Fig. 8. Intrinsic IL-27 signaling is not required for CD8 T cell or B cell 705 
differentiation. WT:Il27ra-/- mixed bone marrow chimeras were infected with 2 x 106 706 
pfu LCMV Cl13 i.v. and at days 9 and 30 p.i. the frequency of (A) DbGP33-41
+ CD8+ T 707 
cells and their PD-1 expression and (B) GL7+ CD38- germinal center B cells and (C) 708 
IgD-CD138+ plasmablasts in the WT (CD45.1+) and Il27ra-/- (CD45.2+) spleen 709 
compartments was determined. Data represents n ≥ 7 mice from 3 independent 710 
experiments.  711 
712 
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